Craenen Kai, Kosiaras Panagiotis, Hellsten Kati
European Chemicals Agency (ECHA), Telakkakatu 6, Helsinki FI-00150, Finland.
European Chemicals Agency (ECHA), Telakkakatu 6, Helsinki FI-00150, Finland.
Neurotoxicology. 2025 Jul;109:11-26. doi: 10.1016/j.neuro.2025.05.006. Epub 2025 May 19.
With the societal interest to decrease experimental animal testing for regulatory purposes, the need for reliable new approach methods (NAMs) has become evident. To ensure the continued safe use of chemicals, NAMs should perform ideally at a comparable or better level of sensitivity and specificity as the in vivo modalities that they aim to replace, especially if they are to be used for hazard assessment. The use of relevant reference substances, selected with transparent criteria, forms a cornerstone of developing and validating (in silico and in vitro) NAMs. Claims on sensitivity and specificity should be based on results generated with reference chemicals that were previously scrutinised by independent expert panels on whether the substance has a hazardous property. CLP (Regulation (EC) No 1272/2008 on the classification, labelling and packaging of substances and mixtures) forms a key pillar in EU chemicals management. The evaluation of all available information by the Committee for Risk Assessment (RAC) and their comparison to CLP classification criteria creates the opportunity to objectively compile lists of positive reference substances. We collated a reference list of neurotoxic substances to aid in the development of neurotoxicity NAMs. We screened CLP Annex VI and reflected on existing reference lists and mode of action data. The identified substances included industrial chemicals and active substances in plant protection products and biocidal products. This list of neurotoxicants is not an exhaustive consensus list, which ideally would be the result of combining this list with those generated by other authorities or expert groups.
随着社会出于监管目的减少实验动物测试的需求日益凸显,对可靠的新方法(NAMs)的需求也变得愈发明显。为确保化学品的持续安全使用,NAMs在灵敏度和特异性方面应达到与它们旨在替代的体内检测方法相当或更好的水平,尤其是在用于危害评估时。使用依据透明标准挑选的相关参考物质,是开发和验证(计算机模拟和体外)NAMs的基石。关于灵敏度和特异性的声明应基于参考化学品产生的结果,这些化学品先前已由独立专家小组审查其是否具有有害特性。《化学品分类、标签和包装法规》(CLP,欧盟法规(EC)No 1272/2008)是欧盟化学品管理的关键支柱。风险评估委员会(RAC)对所有可用信息进行评估,并将其与CLP分类标准进行比较,从而有机会客观地编制阳性参考物质清单。我们整理了一份神经毒性物质参考清单,以协助神经毒性NAMs的开发。我们筛选了CLP附件VI,并参考了现有的参考清单和作用模式数据。确定的物质包括工业化学品以及植物保护产品和杀生物产品中的活性物质。这份神经毒剂清单并非详尽无遗的共识清单,理想情况下,它应是将这份清单与其他当局或专家组编制的清单相结合的结果。